Respiratory syncytial virus (RSV) infection is the primary cause of respiratory infection in young children, causing >120,000 hospitalizations in the US annually. RSV vaccine development has been hampered by the history of a failed vaccine trial in the early 1960s in which vaccinated children were not protected against subsequent natural infection but rather experienced more severe disease. Subsequent experiments in animal models and human subjects suggest the occurrence of severe RSV disease correlates with the induction of virus-specific Th2 CD4 T cells and eosinophil recruitment and degranulation. The G glycoprotein of RSV and killed virus vaccines containing adjuvants such as alum induce these types of immune responses associated with the vaccine-enhanced disease syndrome. In these studies, we have examined the role of the both the antigen, FI-RSV, and immune response to this antigen as well RSV itself to gain insight into immunopathology and enhanced-disease. With our recent stablization of the RSV F protein in the prefusion confirmation, we have identified epitopes that are expressed only on the prefusion form of the F protein. We have applied these findings to better understanding the conformation of the F protein in the FI-RSV vaccine and the specificity of the immune response generated towards the vaccine. Additionally, we have examined the contribution of CD4 T cells and CD8 T cells to immunopathology and viral clearance. CD4 T cells can influence and regulate the function of other immune effectors including CD8 T cells. In addition to the potential role of Th2 CD4 T cells in RSV pathogenesis as mentioned above, T regulatory cells have properties that suggest they may be important in RSV immunity and pathogenesis. We are currently evaluating the recruitment of regulatory T cells during primary and secondary infections.

Project Start
Project End
Budget Start
Budget End
Support Year
16
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Niaid Extramural Activities
Department
Type
DUNS #
City
State
Country
Zip Code
Killikelly, April M; Kanekiyo, Masaru; Graham, Barney S (2016) Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus. Sci Rep 6:34108
Liu, Jie; Haddad, Elias K; Marceau, Joshua et al. (2016) A Numerically Subdominant CD8 T Cell Response to Matrix Protein of Respiratory Syncytial Virus Controls Infection with Limited Immunopathology. PLoS Pathog 12:e1005486
Kines, Rhonda C; Zarnitsyn, Vladimir; Johnson, Teresa R et al. (2015) Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles. PLoS One 10:e0120797
Kiss, Gabriella; Holl, Jens M; Williams, Grant M et al. (2014) Structural analysis of respiratory syncytial virus reveals the position of M2-1 between the matrix protein and the ribonucleoprotein complex. J Virol 88:7602-17
Liu, Jie; Cao, Shirley; Peppers, Gretchen et al. (2014) Clonotype-specific avidity influences the dynamics and hierarchy of virus-specific regulatory and effector CD4(+) T-cell responses. Eur J Immunol 44:1058-68
Graham, Barney S (2013) Advances in antiviral vaccine development. Immunol Rev 255:230-42
Hillyer, Philippa; Raviv, Nataly; Gold, Doria M et al. (2013) Subtypes of type I IFN differentially enhance cytokine expression by suboptimally stimulated CD4(+) T cells. Eur J Immunol 43:3197-208
Collins, Peter L; Fearns, Rachel; Graham, Barney S (2013) Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease. Curr Top Microbiol Immunol 372:3-38
Johnson, Teresa R; Johnson, Christina N; Corbett, Kizzmekia S et al. (2011) Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus. PLoS One 6:e16458
Liu, Jie; Ruckwardt, Tracy J; Chen, Man et al. (2010) Epitope-Specific Regulatory CD4 T Cells Reduce Virus-Induced Illness while Preserving CD8 T-Cell Effector Function at the Site of Infection. J Virol 84:10501-9

Showing the most recent 10 out of 12 publications